Alzheimer'S Disease Knowledge Translation

Alzheimer's Disease knowledge translation involves effectively disseminating scientific findings and clinical insights to various stakeholders, including patients, caregivers, healthcare providers, and policymakers. It aims to bridge the gap between research discoveries and practical application in the management and treatment of Alzheimer's Disease and other forms of dementia. Key components include raising awareness about symptoms and risk factors, promoting early diagnosis through screening programs, educating caregivers on effective caregiving strategies, and advocating for policies that support dementia-friendly communities. Successful knowledge translation enhances public understanding, improves patient care outcomes, and encourages research advancements towards better treatments and, ultimately, a cure for Alzheimer's Disease.

Committee Members
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - London Jacqueline

London Jacqueline

Paris Diderot University, France
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jacqueline Tuppen

Jacqueline Tuppen

Cogs Club, United Kingdom
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Zhenhuan Liu

Zhenhuan Liu

Guangzhou University of Chinese Medicine, China
Tags

Submit your abstract Today

Whatsapp